Instinct Science Competitive Intelligence & Landscape
instinct.vet ·
Overview
Instinct Science Overview
The core products of Instinct Science include practice management software that streamlines workflows, enhances patient care, and boosts revenue capture for veterinary practices. Their platform is designed by veterinary professionals to support real clinical workflows, incorporating features like treatment sheets, patient safety warnings, and decision support tools, which are constantly refined to meet industry needs (instinct.vet). The company’s mission centers on transforming veterinary medicine by creating impactful, user-friendly tools that empower veterinary teams to deliver safer, smarter care (fortune.com).
Targeting veterinary hospitals, especially emergency, specialty, and general practices, Instinct Science has rapidly grown, with over 142 employees and a revenue of approximately $2 million. The company has gained recognition for its innovative approach, including being named to the 2025 Inc. 5000 list of fastest-growing private companies, highlighting its significant market impact and commitment to improving veterinary care (instinct.vet). Its value proposition emphasizes efficiency, accuracy, and better patient outcomes, driven by a team of veterinary and tech experts dedicated to industry advancement.
Sources
Instinct Science - Mainsail Partners Portfolio Companies
mainsailpartners.com
Instinct Science: Better Veterinary Practice Software Today
instinct.vet
Instinct Science Company Profile, Stock Price, News, Rankings | Fortune
fortune.com
Meet Instinct Science | Veterinary & Tech Experts Powering Practices
instinct.vet
Instinct Science Named to the 2025 Inc. 5000 List of Fastest ...
instinct.vet
Instinct Science - Ben Franklin Technology Partners
sep.benfranklin.org
Instinct Science - LinkedIn
linkedin.com
instinct laboratory
instinctlaboratory.com
Instinct Science Weekly Intel Updates
Receive weekly intel updates about Instinct Science straight to your inbox.
Competitors
Instinct Science Competitors
In comparison, TetraScience is a leader in data and AI solutions for scientific research, primarily serving the biotech and pharmaceutical sectors. Its key differentiator is its focus on federated data platforms that enable seamless integration and analysis across decentralized data sources, making it less directly comparable but relevant as a competitor in the broader scientific research software space (cbinsights.com).
Inquisite offers AI-powered research tools for scientific literature and data analysis, with features like visualization, synthesis, and scope filtering for research papers. Its market positioning is geared toward research teams and academic institutions, providing advanced data visualization and analysis capabilities that are not directly comparable to veterinary practice management but serve a similar niche in scientific research support (inquisite.ai).
Rhino Federated Computing specializes in federated AI and data solutions within the technology sector, focusing on connecting decentralized data sources for enterprise AI applications. Its differentiation lies in federated learning and AI solutions that enable data privacy and security, positioning it as an indirect competitor in the broader AI and data platform market (cbinsights.com).
Manifold provides collaborative research tools, emphasizing data science, bioinformatics, and research management. Its platform supports cohort exploration and data insights, primarily targeting research organizations and bioinformatics teams, making it a competitor in scientific research software but not directly in veterinary practice management (cbinsights.com).
Product & Pricing
Instinct Science Product and Pricing Intelligence
In contrast, scienceOS provides a subscription-based pricing structure with a free tier and a paid Angel plan at $7.95 per month, offering unlimited access to features such as PDF uploads, citation analysis, and unlimited queries (scienceos.ai). Their team plans start at $6.59 per user per month with discounts for multiple users, emphasizing scalable solutions for research teams.
Research Guru adopts a token-based model, offering a free trial with 5 tokens and flexible pay-as-you-go options. Basic analyses cost 1 token, while enhanced analyses require 3 tokens, with tokens never expiring and available for purchase in bundles, making it suitable for occasional or ongoing research projects (researchguru.ai). Overall, these platforms provide a range of pricing options, from free tiers to subscription plans and pay-per-analysis models, catering to individual researchers and teams.
Ad Campaigns
Instinct Science Ad Campaigns
Instinct Science is currently running 176 ads across Google, LinkedIn — 47 on Google and 129 on LinkedIn. Explore Instinct Science's live ad creative, messaging, and the platforms they advertise on in the ad library — updated automatically by ForesightIQ.
See of Instinct Science's ads
Browse the live creative across Google, Meta & LinkedIn in the ad library
Hiring & Layoffs
Instinct Science Hiring and Layoffs
While the provided search results do not detail specific recent hiring trends or notable job openings for Instinct Science, they do offer insights into broader industry dynamics. The veterinary field, in general, is experiencing a shortage of professionals due to factors such as an increase in pet ownership and burnout among existing veterinarians (roo.vet). This context implies that companies like Instinct Science would likely be focused on recruitment and retention efforts to address these industry-wide challenges.
The search results do not contain any information regarding layoffs at Instinct Science. However, other technology companies are making strategic workforce adjustments. For instance, Emergence AI plans to hire 500 researchers for a new lab in India (timesofindia.indiatimes.com), while Pinterest cut 15% of its workforce to accelerate an AI-first strategy (devstyler.io). These contrasting moves highlight diverse strategic approaches within the tech and AI sectors.
Sources
The Veterinary Staffing Dilemma: Understanding the Shortage of ...
roo.vet
New Surveys from Instinct Science Reveal Surprising Shifts in ...
finance.yahoo.com
Pinterest Cuts 15% of Workforce as Company Accelerates AI-First Strategy – Devstyler.io
devstyler.io
Emergence AI to hire 500 researchers at new India AI lab
timesofindia.indiatimes.com
Google Research hires Isomorphic Labs AI scientist
edtechinnovationhub.com
Where NVIDIA Is Hiring, According to Its CEO – Devstyler.io
devstyler.io
Leadership
Instinct Science Management and Leadership Team
In recent developments, Caleb Frankel publicly announced the acquisition of ScribbleVet in early 2026, marking a significant strategic move to integrate AI-powered veterinary software into Instinct's offerings. This acquisition aims to enhance the company's veterinary practice management system by combining AI scribing, clinical decision support, and workflow tools into a unified platform (Instinct Vet Blog).
Additionally, Caleb Frankel's background includes experience as an ER veterinarian and a founder dedicated to veterinary innovation, with a strong focus on improving practice management software for veterinary hospitals. His leadership is characterized by a commitment to technological advancement and clinical support, positioning Instinct Science as a leader in veterinary practice software (CB Insights, Instinct Vet).
Sources
Instinct Science Management Team | Org Chart - RocketReach
rocketreach.co
Instinct Science CEO Speaks On Acquiring ScribbleVet
instinct.vet
Instinct Science: Better Veterinary Practice Software Today
instinct.vet
Instinct Science Management Team - CB Insights
cbinsights.com
Meet Instinct Science | Veterinary & Tech Experts Powering Practices
instinct.vet
Caleb Frankel, VMD - Instinct Science - LinkedIn
linkedin.com
Eric Isaacs Named Next RCSA President
rescorp.org
Leadership updates for Lehigh’s materials research institute | P.C. Rossin College of Engineering & Applied Science
engineering.lehigh.edu
Financials
Instinct Science Financial Performance, Fundraising, M&A
Financial health indicators suggest that the company is expanding rapidly, supported by its valuation and funding rounds, although specific valuation figures are not publicly disclosed. The company was founded in 2017 and has attracted notable investors, which has helped fuel its growth in veterinary practice management software (PitchBook). M&A activity appears limited, with only one recorded transaction, reflecting a focus on organic growth and product development rather than acquisitions (Mergr). Overall, Instinct Science demonstrates strong financial health, evidenced by increasing revenues and ongoing investment, positioning it well for continued expansion in the veterinary tech sector.
Sources
Instinct Science Stock Price, Funding, Valuation, Revenue ...
cbinsights.com
How Instinct Science hit $8.2M revenue with a 68 person team in...
getlatka.com
Instinct Science - Valuation, Funding & Investors - PitchBook
pitchbook.com
Instinct Science - M&A Summary and Business Overview
mergr.com
New Surveys from Instinct Science Reveal Surprising Shifts in ...
finance.yahoo.com
Instinct Science - 2026 Company Profile & Team - Tracxn
tracxn.com
Instinct Science - Funding & Investors
tracxn.com
Instinct - Funding & Investors
tracxn.com
Partnerships
Instinct Science Partnerships, Clients and Vendors
VetMedux is known for its educational resources and point-of-care information, including Clinician’s Brief and Plumb’s Veterinary Drugs, reaching over 260,000 veterinarians globally [1].
Further expanding its technological capabilities, Instinct Science acquired ScribbleVet in January 2026 [4]. This acquisition integrates AI scribing and decision support into Instinct Science's offerings, creating what they describe as the industry's first clinical intelligence platform. This platform aims to move beyond traditional record-keeping by embedding AI and intelligence-native workflows into their practice management system, Instinct EMR [4].
ScribbleVet's founder and CEO, Rohan Relan, has joined Instinct Science to lead product strategy for intelligence products [4].
Instinct Science has also been recognized for its rapid growth, being named to the 2025 Inc. 5000 list of fastest-growing private companies in America [2]. This growth is attributed to their mission of improving patient care, increasing efficiency, and driving better outcomes for veterinary teams worldwide through their connected family of tools [2]. The company offers a demo of the Instinct EMR and highlights integrations such as the one with ScribbleVet [2].
While not directly a partner or client of Instinct Science, other industry developments include Inizio Ignite, which encompasses Research Partnership, Putnam, Vynamic, and STEM, serving as a global advisory partner for health and life sciences [5, 7]. Additionally, Basis Global and AnswerRocket have formed a strategic partnership to redefine market research using AI [6]. In the broader tech landscape, Oracle and AMD have partnered to challenge NVIDIA in the AI GPU market by deploying a significant number of AMD Instinct MI450 Series GPUs on Oracle Cloud Infrastructure [8].
Sources
Instinct Science Acquires VetMedux - Mainsail Partners
mainsailpartners.com
Instinct Science Named to the 2025 Inc. 5000 List of Fastest ...
instinct.vet
VetMedux - 2026 Company Profile, Team & Competitors - Tracxn
tracxn.com
Instinct Science Acquires ScribbleVet for Smarter Software
instinct.vet
research partnership
inizio.com
Basis Global and AnswerRocket Launch Strategic Partnership to Redefine Market Research in the Age of AI
businesswire.com
Our teams | Inizio Ignite: RP, Putnam, Vynamic, STEM
researchpartnership.com
Oracle and AMD Join Forces to Challenge NVIDIA in the AI GPU Arena | AI News
opentools.ai
Events
Instinct Science Event Participations
Frequently Asked Questions
What does Instinct Science's acquisition of ScribbleVet in early 2026 signal about where they're taking their product platform?
The ScribbleVet acquisition signals that Instinct Science is repositioning from a pure practice management system into what it calls the veterinary industry's first 'clinical intelligence platform' — combining AI scribing, clinical decision support, and workflow tools in a single EMR. ScribbleVet's founder Rohan Relan joined Instinct to lead product strategy for intelligence products, indicating this is a sustained roadmap commitment, not a bolt-on feature. For competitors still offering standalone PIMS or scribing tools, this vertical integration raises the switching cost significantly.
Is Instinct Science's revenue trajectory a signal of sustainable growth or an inflated near-term spike?
The trajectory looks like genuine acceleration: revenue grew from the $1–5M range in 2021 to a reported $8.2M in 2023, a meaningful step-up for a company that has raised only approximately $4.17M in disclosed funding. The capital-efficient growth profile — one recorded M&A transaction, primary focus on organic expansion, and Mainsail Partners backing since the November 2022 growth equity round — suggests the revenue increase reflects customer adoption rather than acquisition-driven inflation. That said, profitability data is not publicly disclosed, so burn rate relative to this revenue base remains opaque.
What does Instinct Science's 2024 acquisition of VetMedux tell us about their distribution and go-to-market strategy?
The VetMedux acquisition gave Instinct Science direct access to the largest clinical reference ecosystem in veterinary medicine — Clinician's Brief and Plumb's Veterinary Drugs reach over 260,000 veterinarians globally. This is a distribution and engagement play as much as a product play: embedding Instinct's EMR and clinical tools into content that vets already use daily dramatically lowers customer acquisition friction. Combined with the ScribbleVet deal, the pattern is a deliberate content-and-workflow flywheel, tying clinical education, drug references, AI scribing, and practice management into one platform.
Instinct Science was founded by a practicing ER vet — does that founder-market fit actually show up in their product differentiation?
Yes, in concrete ways. The platform is built around real ER and specialty clinical workflows — treatment sheets, patient safety warnings, and decision support tools — rather than retrofitted billing or scheduling software. CEO Caleb Frankel's background as an ER veterinarian directly shaped the design philosophy, and the company markets this explicitly. The March 2026 webinar 'Say Goodbye to After-Hours Charting' further reflects acute pain points specific to emergency practice workflows, suggesting product development continues to be driven by clinical insight rather than generic SaaS feature roadmaps.
What does the hiring of a Chief People Officer and Chief Revenue Officer tell us about Instinct Science's current organizational phase?
The presence of both a Chief People Officer (Jenna Brown) and a Chief Revenue Officer (Jennifer Mellet) on an 11-person leadership team at a sub-$10M revenue company indicates Instinct Science is deliberately building the management infrastructure for a scaling phase, not just staying lean. The CPO hire is particularly notable given the company's own survey data flagging staff retention and workplace flexibility as top priorities across the veterinary sector — they appear to be applying that insight internally. The CRO hire signals a move toward more structured, repeatable revenue motions consistent with a growth-equity-backed trajectory.
How does Instinct Science's competitive positioning hold up against the major PIMS vendors in veterinary practice management?
Instinct Science differentiates on clinical workflow depth — treatment sheets, safety alerts, decision support — built by veterinarians for veterinarians, whereas legacy PIMS vendors (not named in available data) tend to be billing-first platforms adapted to clinical use. The ScribbleVet and VetMedux acquisitions extend that gap by adding AI scribing and the industry's most widely used drug reference. However, with only ~142 employees and $8.2M in revenue, Instinct remains significantly smaller than established veterinary software incumbents, making enterprise contract competition and deep integrations potential pressure points. The notable competitors identified in available intelligence — TetraScience, Rhino, Manifold — are not direct PIMS competitors, suggesting Instinct's true competitive set is not yet well-mapped in public databases.
What is the strategic logic behind Mainsail Partners backing Instinct Science, and what does that investor profile imply for exit trajectory?
Mainsail Partners is a growth equity firm focused on bootstrapped or capital-efficient B2B SaaS companies, which fits Instinct Science's profile — founder-led, modest prior fundraising (~$4.17M total disclosed), and strong revenue growth. Mainsail's typical playbook involves professionalizing go-to-market and leadership (consistent with the CRO and CPO hires), then positioning for a strategic sale to a larger health IT or veterinary services consolidator. The VetMedux and ScribbleVet acquisitions, funded under Mainsail's watch, suggest the firm is actively building platform scale ahead of an eventual exit rather than optimizing for standalone profitability.
Instinct Science's own 2026 survey data says staff turnover is 'manageable' in vet practices — does that soften the urgency around their workflow efficiency pitch?
Not materially. The same survey data highlights that practices are prioritizing staff retention and workplace flexibility, which means the cost of losing trained staff is front-of-mind even when turnover rates appear stable. Instinct's pitch — reducing after-hours charting burden, streamlining clinical workflows, and cutting administrative friction — addresses the drivers of burnout and turnover rather than turnover as a lagging metric. The March 2026 webinar title 'Say Goodbye to After-Hours Charting' is a direct response to this data, suggesting Instinct is actively using its own research to sharpen its value proposition.
What does Instinct Science's appearance on the 2025 Inc. 5000 list imply about their growth rate, and does the financial data support it?
Inc. 5000 inclusion requires a minimum three-year revenue CAGR that places a company among the fastest-growing private firms in the U.S. Given the move from sub-$5M in 2021 to $8.2M in 2023, Instinct Science's growth rate is credible for that threshold. With acquisitions of VetMedux (January 2024) and ScribbleVet (January 2026) layered on top of the organic baseline, revenue in 2024–2026 has likely accelerated further, though those figures are not publicly confirmed. ForesightIQ continues to track disclosed financial signals as they become available.
ScribbleVet's founder joining Instinct to lead 'intelligence product strategy' — is that a retention incentive or a real organizational signal?
It reads as a substantive organizational signal rather than a cosmetic retention title. Rohan Relan taking ownership of intelligence product strategy for a company that just repositioned itself as a 'clinical intelligence platform' gives the acquired product line a dedicated internal champion with founder-level domain knowledge. This structure — rather than folding the acquisition into an existing PM team — suggests Instinct Science views AI-native clinical tools as a distinct product motion requiring separate leadership, which is consistent with the ambition to move beyond EMR record-keeping into embedded intelligence workflows.
With total disclosed funding of only ~$4.17M, how is Instinct Science financing acquisitions like VetMedux and ScribbleVet?
The $4.17M figure reflects disclosed venture-stage rounds prior to the November 2022 growth equity round led by Mainsail Partners. Growth equity rounds are typically not fully disclosed in seed/Series databases and are often structured as larger capital infusions — likely in the $10M–$50M range for a company at Instinct's stage, though the exact amount is not publicly confirmed. The ability to execute two acquisitions within roughly 24 months of the Mainsail round strongly implies significantly more capital than the $4.17M aggregate suggests. Analysts should treat the disclosed funding figure as an undercount of actual capital deployed.
What does Instinct Science's event and content strategy — webinars, the 'State of General Practice' report — reveal about how they're building pipeline?
Instinct Science is running a content-led demand generation model aimed at positioning the company as a thought leader in veterinary practice operations, not just a software vendor. Proprietary research like the 2026 'State of General Practice Veterinary Care' report generates owned data that drives media coverage, conference presence, and sales conversations simultaneously. Paired with practitioner-focused webinars on specific workflow pain points, this approach targets buyers (practice owners and managers) at the moment they're thinking about operational problems — a classic PLG-adjacent motion for a clinical SaaS company where direct outbound selling to veterinary hospitals is expensive and trust-dependent.
Powered by ForesightIQ · Competitive intelligence from digital exhaust